Omicron-Containing Covid-19 Vaccine | NEJM

Vaccination after Covid-19 Recovery | NEJMПодробнее

Covid-19 Vaccination and the Omicron VariantПодробнее

Vaccine for COVID-19 | NEW Paper NEJM with Phase I Clinical Trial for mRNA-1273 Coronavirus VaccineПодробнее

NEJM Interview: Dr. David Morens on the need for developing broadly protective coronavirus vaccines.Подробнее

Rolling Out New Covid-19 VaccinesПодробнее

VV116 for Oral Treatment of Covid-19 | NEJMПодробнее

mRNA Covid-19 Vaccination in U.S. Health Care Personnel | NEJMПодробнее

Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine | NEJMПодробнее

BNT162b2 Vaccine Booster and Mortality | NEJMПодробнее

NEJM Interview: Dr. Nicole Lurie on rapid vaccine development, including new tools to facilitate ...Подробнее

Making Covid-19 Vaccines Available around the WorldПодробнее

What to Expect from Covid-19 VaccinesПодробнее

A New Monoclonal Antibody for Covid-19 and Potential Vaccination for ChildrenПодробнее

Can We Make More Effective Covid-19 Vaccines?Подробнее

A New Look at Covid-19 Vaccine BoostersПодробнее

Effectiveness of Covid-19 Vaccination in ChildrenПодробнее

Using Our Covid-19 Experience to Develop Vaccines More QuicklyПодробнее

How Effective is Covid-19 Vaccination in Children?Подробнее

Covid-19 Vaccines and the FDAПодробнее